Management Credibility Analysis

Unavailable
Verified Management Score Unavailable
Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed
Verified Catalysts Unavailable
No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive
Not disclosed
Headquarters
79 NEW OXFORD STREET, LONDON, X0
Founded
Not disclosed

📈 Company Timeline

Major business events
Positive
Negative
Neutral
13 Oct 2026

GSK plc securities registration filing

GSK plc filed a registration or prospectus document concerning securities.

14 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in GSK plc.

15 Jul 2026

GSK plc tender offer filing

GSK plc filed Schedule TO-T/A (amended third-party tender offer).

10 Jul 2026

GSK plc tender offer filing

GSK plc filed Schedule TO-T/A (amended third-party tender offer).

8 Jul 2026

GSK plc tender offer filing

GSK plc filed Schedule TO-T/A (amended third-party tender offer).

Capital Structure & Financial Position

Financial strength and liquidity analysis
Verified Capital Structure Unavailable
Balance-sheet, credit-rating, debt, and capital-activity data require sourced financial statement ingestion.

Peer Comparison - Health Care

Company Price Market Cap
LLY - Eli Lilly and Company $1,276.13
Yahoo Finance 		$1.20T
JNJ - Johnson & Johnson $256.74
Yahoo Finance 		$618.71B
ABBV - AbbVie Inc. $284.80
Yahoo Finance 		$503.28B
UNH - UnitedHealth Group Incorporated $418.43
Yahoo Finance 		$375.58B
MRK - Merck & Co., Inc. $148.55
Yahoo Finance 		$366.50B

📋 Corporate Actions

Recent and upcoming corporate events
Verified Corporate Actions Unavailable
Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis
Verified Financial Statements Unavailable
Verified financial statement data is not ingested for this stock yet.

Analyst Consensus

Neutral
Target: $65.00
28.4% upside potential
📈
Strong Buy
Unavailable
👍
Buy
0
⏸️
Hold
1
📉
Sell
0
1 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved Targets range 60.00–70.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments
Verified Dividend Data Unavailable
Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable
Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity
11
Dec 2025
GSK plc
10% owner
Open-market purchase
$19.00 per share
1,470,000 shares
SEC Form 4
27
Sep 2024
GSK plc
10% owner
Open-market purchase
$8.00 per share
2,791,930 shares
SEC Form 4
7
Dec 2023
GSK plc
10% owner
Open-market purchase
$5.00 per share
3,300,000 shares
SEC Form 4
16
Sep 2022
GSK PLC
Other
$9.75 per share
9,644,807 shares
SEC Form 4

Top Shareholders

Fmr Llc
64,961,641 shares
-3.99% change
6/30/2026
Dodge & Cox
48,197,514 shares
-17.84% change
6/30/2026
Fisher Asset Management, Llc
35,722,792 shares
3.477% change
6/30/2026
Primecap Management Co/Ca/
25,182,068 shares
-0.089% change
6/30/2026
Wellington Management Group Llp
11,396,249 shares
-2.743% change
6/30/2026
Jtc Employer Solutions Trustee Ltd
8,592,987 shares
-4.97% change
6/30/2026
Morgan Stanley
7,657,562 shares
-30.579% change
6/30/2026
Royal Bank Of Canada
7,588,928 shares
1.094% change
6/30/2026
Price T Rowe Associates Inc /Md/
6,923,642 shares
-5.451% change
6/30/2026
Acadian Asset Management Llc
6,660,434 shares
-43.542% change
6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed · 19 hours ago